Amarin Corporation PLC

Drug Manufacturers-General

Prices are adjusted according to historical splits.

Amarin Corporation PLC Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$743.19 million
Book Value:
Revenue TTM:
$369.19 million
Operating Margin TTM:
Gross Profit TTM:
$260.56 million
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Amarin Corporation PLC had its IPO on 1993-04-01 under the ticker symbol AMRN.

The company operates in the Healthcare sector and Drug Manufacturers-General industry. Amarin Corporation PLC has a staff strength of 365 employees.

Stock update

Shares of Amarin Corporation PLC opened at $1.55 at the start of the last trading session i.e. 2023-03-30.

The stocks traded within a range of $1.47 - $1.55, and closed at $1.54.

This is a 0% increase from the previous day's closing price.

A total volume of 2,246,258 shares were traded at the close of the day’s session.

In the last one week, shares of Amarin Corporation PLC have increased by +0.65%.

Amarin Corporation PLC's Key Ratios

Amarin Corporation PLC has a market cap of $743.19 million, indicating a price to book ratio of 0.7969 and a price to sales ratio of 1.1826.

In the last 12-months Amarin Corporation PLC’s revenue was $369.19 million with a gross profit of $260.56 million and an EBITDA of $-71169000. The EBITDA ratio measures Amarin Corporation PLC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Amarin Corporation PLC’s operating margin was -20.12% while its return on assets stood at -4.75% with a return of equity of -16.76%.

In Q4, Amarin Corporation PLC’s quarterly earnings growth was a negative -94.2% while revenue growth was a negative 37.5%.

Amarin Corporation PLC’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-0.22 per share while it has a forward price to earnings multiple of 500 and a PEG multiple of -1.74. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Amarin Corporation PLC’s profitability.

Amarin Corporation PLC stock is trading at a EV to sales ratio of 0.4792 and a EV to EBITDA ratio of -2.2825. Its price to sales ratio in the trailing 12-months stood at 1.1826.

Amarin Corporation PLC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$886.18 million
Total Liabilities
$259.48 million
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Amarin Corporation PLC ended 2023 with $886.18 million in total assets and $0 in total liabilities. Its intangible assets were valued at $886.18 million while shareholder equity stood at $595.33 million.

Amarin Corporation PLC ended 2023 with $0 in deferred long-term liabilities, $259.48 million in other current liabilities, 299002000.00 in common stock, $-1527251000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $217.67 million and cash and short-term investments were $309.36 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Amarin Corporation PLC’s total current assets stands at $689.10 million while long-term investments were $0 and short-term investments were $91.70 million. Its net receivables were $130.99 million compared to accounts payable of $64.60 million and inventory worth $228.73 million.

In 2023, Amarin Corporation PLC's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Amarin Corporation PLC paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Amarin Corporation PLC stock is currently trading at $1.54 per share. It touched a 52-week high of $3.74 and a 52-week low of $3.74. Analysts tracking the stock have a 12-month average target price of $3.57.

Its 50-day moving average was $1.78 and 200-day moving average was $1.45 The short ratio stood at 2.17 indicating a short percent outstanding of 0%.

Around 48.1% of the company’s stock are held by insiders while 3417.9% are held by institutions.

Frequently Asked Questions About Amarin Corporation PLC

The stock symbol (also called stock or share ticker) of Amarin Corporation PLC is AMRN

The IPO of Amarin Corporation PLC took place on 1993-04-01

Similar Industry Stocks (Drug Manufacturers-General)

Last Price
Basanite Inc (BASA)

Most Active

Last Price

Top Gainers

Last Price

Top Losers

Last Price


Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.


Grand Canal Docklands, Dublin, Ireland, 2